Academic Journals Database
Disseminating quality controlled scientific knowledge

3-O-Methylfunicone, a Selective Inhibitor of Mammalian Y-Family DNA Polymerases from an Australian Sea Salt Fungal Strain

ADD TO MY LIST
 
Author(s): Yoshiyuki Mizushina | Hirohisa Motoshima | Yasuhiro Yamaguchi | Toshifumi Takeuchi | Ken Hirano | Fumio Sugawara | Hiromi Yoshida

Journal: Marine Drugs
ISSN 1660-3397

Volume: 7;
Issue: 4;
Start page: 624;
Date: 2009;
Original page

Keywords: 3-O-methylfunicone | Y-family DNA polymerase | DNA polymerase κ | enzyme inhibitor | marine fungal strains | Australian sea salt | anti-cancer drug

ABSTRACT
We isolated a pol inhibitor from the cultured mycelia extract of a fungal strain isolated from natural salt from a sea salt pan in Australia, which was identified as 3-O-methylfunicone by spectroscopic analyses. This compound selectively inhibited the activities of mammalian Y-family DNA polymerases (pols) (i.e., pols η, ι and κ). Among these pols, human pol κ activity was most strongly inhibited, with an IC50 value of 12.5 μM. On the other hand, the compound barely influenced the activities of the other families of mammalian pols, such as A-family (i.e., pol γ), B-family (i.e., pols α, δ and ε) or X-family (i.e., pols β, λ and terminal deoxynucleotidyl transferase), and showed no effect on the activities of fish pol δ, plant pols, prokaryotic pols and other DNA metabolic enzymes, such as calf primase of pol α, human immunodeficiency virus type-1 (HIV-1) reverse transcriptase, human telomerase, T7 RNA polymerase, mouse IMP dehydrogenase (type II), human topoisomerases I and II, T4 polynucleotide kinase or bovine deoxyribonuclease I. This compound also suppressed the growth of two cultured human cancer cell lines, HCT116 (colon carcinoma cells) and HeLa (cervix carcinoma cells), and UV-treated HeLa cells exhibited lower clonogenic survival in the presence of inhibitor.
Why do you need a reservation system?      Save time & money - Smart Internet Solutions